Sécurité et efficacité de l’oxyhydroxyde sucroferrique dans les conditions réelles de la pratique chez des patients dialysés en France : analyse intermédiaire de sous-groupe de l’étude VERIFIE
Denis Fouque(Université Claude Bernard Lyon 1), Jacques Rottembourg, Anja Derlet(Fresenius Medical Care North America (United States)), Charles Chazot(Clinique Charcot), P Brunet(Metabolism and Renal Physiology), Sebastian Walpen(Vifor Pharma (Switzerland)), Philippe Chauveau, Gabriel Choukroun(Centre Hospitalier Universitaire Amiens-Picardie), Manuela Stauss‐Grabo(Fresenius Medical Care (Germany)), Thierry Hannedouche
Cited by 0
Related Papers
Survival as an index of adequacy of dialysis
|Kidney International|1992|769
Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference
|Kidney International|2020|724
Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population
|Nephrology Dialysis Transplantation|2010|478
Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement
|Nephrology Dialysis Transplantation|2013|476